Nucynta Extended-Release 150 mg (Tapentadol (Tapentadol Hydrochloride) TABLET (EXTENDED-RELEASE)) 150 MG

NUCYNTA Extended-Release 150 MG is a prescription medication containing tapentadol hydrochloride, designed for extended pain relief. This extended-release tablet is used to manage moderate to severe chronic pain over an extended period.

Strength

150 MG

Pack Size

Manufacturer / TM Owner

ENDO OPERATIONS LTD.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

NUCYNTA Extended-Release 150 MG is primarily used for the management of moderate to severe chronic pain. The extended-release formulation is designed to provide prolonged pain relief, making it suitable for conditions that require consistent pain management. Tapentadol, the active ingredient, works by affecting the way the body perceives pain signals.

Side Effects

Common effects of NUCYNTA Extended-Release 150 MG may include drowsiness, dizziness, nausea, and constipation. Some users may also experience headaches or dry mouth. These effects can vary from person to person and may diminish over time as the body adjusts to the medication.

Precautions & Warnings

NUCYNTA Extended-Release 150 MG should be taken exactly as prescribed by a healthcare provider. It is important to swallow the tablet whole and not crush, chew, or break it, as this can affect the extended-release mechanism. Patients should avoid alcohol and other central nervous system depressants while taking this medication.

Avoid Interactions

NUCYNTA Extended-Release 150 MG may interact with other medications, including alcohol, antidepressants, and other pain relievers. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Always consult a healthcare professional before starting or stopping any medication.

Frequently Asked Questions

NUCYNTA Extended-Release 150 MG is used for the management of moderate to severe chronic pain over an extended period.

NUCYNTA Extended-Release 150 MG should be taken orally, swallowed whole, and not crushed, chewed, or broken.

Common side effects may include drowsiness, dizziness, nausea, and constipation.

It is generally advised to avoid alcohol while taking NUCYNTA Extended-Release 150 MG due to potential interactions.

If you miss a dose, take it as soon as you remember, unless it is almost time for your next dose. Do not double the dose to catch up.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.